Find breaking developments on novel tumor-killing strategies and pipeline projects:

Hear Preclinical and Clinical Data:

Tumor microenvironment projects from: AstraZeneca Novartis Genentech AVEO Exelixis Plexxikon Calistoga Array Ortho Biotech Amgen Abbott

Cancer stem cell projects from: Genentech Macrogenics Micromet TRION Stemline AstraZeneca Oncomed Geron Cellerant

Learn from multiple case studies covering:

• Cancer stem cells, tumor initiating cells and the stem cell niche
• Strategies targeting the inflammatory component of tumors
• Tumor-killing strategies targeting key drivers of tumor growth
• Data from multiple compounds in development

This conference provides data from cancer stem cell-targeted drugs in development and explores therapeutics targeting the inflammatory component of tumors.

»Conference Agenda
»List of Speakers

Why Attend?

A growing body of evidence indicates that the tumor microenvironment contributes to tumor growth and viability, while significant advances are being made in the understanding of cancer stem cells and tumor initiating cells.

Attendees of this conference will hear from these world-renowned cancer researchers and drug developers who will discuss data from their latest projects:

• Andrew Fire, Ph.D., Stanford University School of Medicine
• Jeffrey W. Pollard, Ph.D., Albert Einstein College of Medicine
• Napoleone Ferrara, M.D., Genentech, Inc.
• Patrick Baeuerle, Ph.D., Micromet, Inc.
• Elsa Quintana, Ph.D., University of Michigan

Who Attends?

Chief Scientific Officers, Vice Presidents, Directors, Managers, Heads of Departments, Group/Team/Project Leaders, Scientists, Investigators and Researchers working in the following areas:

• Oncology R&D
• Cancer Biology
• Hematology
• Drug Discovery R&D
• Lead Discovery
• Genetics
• Pharmacogenomics
• Biomarkers
• Translational Research
• Clinical Science/R&D
• Drug Delivery
• Antibody Discovery
• Protein Sciences
• Exploratory Clinical Development
• Medical Sciences

»See who is already registered to attend

Receive Complimentary MedTRACK access when you register for Drug Discovery and Development Week.

Life Science Analytics and IBC Life Sciences are teaming up to provide complimentary MedTRACK access for attendees of the Drug Discovery and Development Week.

MedTRACK helps track competitors, find partners, identify new markets, and aid in conference and meeting preparation.

MedTRACK provides a centralized resource for company, product, deal, patent, and epidemiology information.

Registered attendees will receive an e-mail regarding the registration process one week prior to the start of the complimentary access, which is valid from July 26th through August 9th. This is an incredible value - so don't miss it!